Key result
Relative risk reduction, absolute risk reduction, and number needed to treat are key metrics for measuring the size of a treatment effect.
Key points are not available for this paper at this time.
Clinicians should integrate absolute risk metrics into shared decision-making; leaves open standardization across ophthalmology trials.
No takes yet. Share an insight, caveat, or question.
Hollands et al. (2008) studied this question. Relative risk reduction, absolute risk reduction, and number needed to treat are key metrics for measuring the size of a treatment effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: